{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:55:59Z","timestamp":1771955759626,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00875","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T10:15:07Z","timestamp":1576232107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Randomized, Controlled Pilot Study of Low-Dose Human Chorionic Gonadotropin Administration Beginning From the Early Follicular Phase for Women With Polycystic Ovarian Syndrome Undergoing Ovarian Stimulation Using the Progesterone Protocol"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiuxian","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"CD005354","DOI":"10.1002\/14651858.CD005354.pub2","article-title":"Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles","volume":"2","author":"van Wely","year":"2011","journal-title":"Cochr Database Syst Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0015-0282(16)59109-2","article-title":"Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles","volume":"47","author":"Blankstein","year":"1987","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1210\/jc.84.8.2659","article-title":"Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome","volume":"84","author":"Filicori","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1210\/jcem.87.3.8322","article-title":"Stimulation and growth of antral ovarian follicles by selective LH activity administration in women","volume":"87","author":"Filicori","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0015-0282(03)00594-6","article-title":"Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle stimulating hormone","volume":"80","author":"Filicori","year":"2003","journal-title":"Fertil Steril"},{"key":"B6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.fertnstert.2005.02.036","article-title":"Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation","volume":"84","author":"Filicori","year":"2005","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.fertnstert.2005.02.033","article-title":"Novel concepts of human chorionic gonadotropin: Reproductive system interactions and potential in the management of infertility","volume":"84","author":"Filicori","year":"2005","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.fertnstert.2004.07.084","article-title":"A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low dose hCG","volume":"82","author":"Kyono","year":"2004","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e909","DOI":"10.1097\/MD.0000000000000909","article-title":"Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"94","author":"Zhu","year":"2015","journal-title":"Medicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e4193","DOI":"10.1097\/MD.0000000000004193","article-title":"The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF\/ICSI treatments","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.fertnstert.2016.10.030","article-title":"Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a \u201cfreeze all\u201d strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg","volume":"107","author":"Zhu","year":"2017","journal-title":"Fertil Steril."},{"key":"B12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1038\/s41598-017-08472-2","article-title":"Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/humrep\/des256","article-title":"A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization","volume":"27","author":"Thuesen","year":"2012","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0197-2456(88)90049-9","article-title":"Randomization in clinical trials: conclusions and recommendations","volume":"9","author":"Lachin","year":"1988","journal-title":"Control Clin Trials"},{"key":"B16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1477-7827-7-110","article-title":"Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation","volume":"7","author":"Drakakis","year":"2009","journal-title":"Reprod Biol Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.fertnstert.2006.12.051","article-title":"Recombinant follicle-stimulating hormone (rFSH). supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization","volume":"88","author":"Van Horne","year":"2007","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1210\/jc.2013-1528","article-title":"Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization","volume":"99","author":"Thuesen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.6061\/clinics\/2014(04)10","article-title":"Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech","volume":"69","author":"Leao Rde","year":"2014","journal-title":"Clinics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jcem.76.4.8473415","article-title":"Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-development, oocyte maturation, and subsequent luteal function","volume":"76","author":"Zelinski Wooten","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1095\/biolreprod41.1.15","article-title":"Effects of luteinizing hormone on superovulatory and steroidogenic responses of rat ovaries to infusion with follicle-stimulating hormone","volume":"40","author":"Opavsky","year":"1989","journal-title":"BioI Reprod"},{"key":"B22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1210\/endo-97-2-366","article-title":"Evidence of a role of androgens in follicular maturation","volume":"97","author":"Louvet","year":"1975","journal-title":"Endocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1095\/biolreprod41.1.54","article-title":"Bimodal effects ofluteinizing hormone and role of androgens in modifying superovulatory responses of rats to infusion with purified porcine follicle-stimulating hormone","volume":"41","author":"Armstrong","year":"1989","journal-title":"BioI Reprod"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/humrep\/den131","article-title":"Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial","volume":"23","author":"Lossl","year":"2008","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1095\/biolreprod.105.047407","article-title":"Distinct regulation by steroids of messenger RNAs for FSHR and CYP19A1 in bovine granulosa cells","volume":"75","author":"Luo","year":"2006","journal-title":"Biol Reprod"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.fertnstert.2011.09.044","article-title":"Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization\/intracytoplasmic sperm injection: a prospective randomized study","volume":"96","author":"Mansour","year":"2011","journal-title":"Fertil Steril"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T10:15:08Z","timestamp":1576232108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":28,"alternative-id":["10.3389\/fendo.2019.00875"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00875","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"article-number":"875"}}